Project Details
Description
PROJECT SUMMARY/ABSTRACT
Coordinated gastrointestinal (GI) tract motility is fundamental for normal GI tract function. Several cell types
combine to regulate GI motility, with the smooth muscle cell (SMC) as the workhorse required to provide the
physical power for contractions. Disruptions in SMC function contribute to common GI disorders, may occur after
infections and inflammation, and associate with rare but devastating GI motility disorders like visceral myopathies
and pseudo-obstruction. The gut wall is a highly complex multilayered structure under mechanical stress at
baseline and constantly moving. Therefore, cells in the GI tract experience a range of types and amounts of
mechanical stimuli. The normal coordinated motility requires an ability to sense and adjust to forces. In multiple
cycles of this grant, we have dissected mechanisms of smooth muscle mechanotransduction, have made
discoveries that advanced GI physiology and pathophysiology, and provided novel drug targets. However, our
current understanding of SMC mechanosensing remains incomplete. It is established that SMCs, even as single
cells, adjust their contractions in response to force in a process called the myogenic reflex. In vascular SMCs,
the myogenic reflex depends on mechanogated ion channels, but in the GI tract, cellular and molecular
mechanisms remain poorly understood. Therefore, the overall objective of our research is to determine the
primary mechanogated ion channels involved in GI SMC mechanosensitivity. For this proposal, we created novel
animal models and used cutting-edge techniques to generate compelling preliminary data. Our preliminary
studies show that a recently discovered mechanogated ion channel Tmem63a is expressed in a subpopulation
of SMCs, which are optimized for force sensing and distributed across the tissue to detect force. Indeed
mechanosensitive ionic currents in a population of primary mouse GI SMCs have unique biophysical properties
consistent with Tmem63a, the activation of which by force leads to a Ca2+ increase, modulating small and large
bowel contractions and whole gut transit time. Interestingly, our data also show that patients with slow transit
constipation have a decrease in Tmem63a. Thus, the central hypothesis that a mechanogated ion channel
Tmem63a significantly contributes to the myogenic reflex will be tested in two Aims. In Aim 1, we determine
Tmem63a function, its response to force, and its role in GI SMCs using conventional and cutting-edge techniques
electrophysiology and Ca2+ imaging approaches. In Aim 2, we propose experiments to define the Tmem63a+
SMC population and to determine the role of Tmem63a SMCs in regulating GI smooth muscle function. Since
Tmem63a is found in a subpopulation of SMCs, we use single-cell and spatial transcriptomics, novel Ca2+
imaging, smooth muscle contractility assays and in vivo whole gut transit. Successful completion of the proposed
innovative experiments has both basic significance and clinical impact, evaluating and establishing a novel SMC
mechanogated ion channel which contributes to SMC function and the myogenic reflex and, in the long term,
may provide a novel target for functional and motility GI disorders.
Status | Active |
---|---|
Effective start/end date | 9/1/97 → 3/31/24 |
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases: $345,825.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $143,100.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $345,825.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $549,720.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $357,750.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $357,750.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $289,080.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $345,825.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $317,877.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $333,722.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $321,088.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $143,100.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $549,415.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.